Stories

Ipsen is proud to launch our ‘A Life in Science’ campaign, spotlighting the talented and passionate individuals who are making their mark and driving innovation. 

Our performance in 2024 confirmed that our strategic initiatives are paying off, with significant advancements and robust financial growth across all three therapeutic areas: Oncology, Rare Disease and Neuroscience.

Despite progress in gender equality, women remain underrepresented in STEM, making up just 1/3 of the workforce compared to 1/2 in non-STEM fields.1  

While being diagnosed with cancer isn’t unique- around 20m people are diagnosed with cancer globally each year, and that number is projected to double in next 20 years—how it affects each person is.

The financial results for the Full Year 2024 will be published on February 13, 2025 at 7H00 CET and a conference call will take place at 13H00 CET.